More PRNewswire
View Older Stories View Newer Stories-
Vinamilk Earns Multiple Accolades in 2023 Brand Rankings, Underlining Its Commitment to Sustainability
-
Cars On the Lookout: IDTechEx Explores Image Sensors and Radars in Vehicles
-
IDTechEx Forecasts Material Innovation to Drive the Water Electrolyzer Market
-
CHiQ Debuts at FIS Ski Jumping World Cup 2023
-
EQL Financial Technologies Launches Filings.AE & LEDGERS Platform for UAE
-
Global Times: China's Putonghua lives up to its name as language of the people
-
Azentio Software wins double honours at IBSi Global FinTech Innovation Awards 2023
-
Hoba Therapeutics raises EUR 23 million in a Series A to advance new drug candidate against chronic neuropathic pain
-
ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*
-
Medtronic and Cosmo Pharmaceuticals forge ahead in AI-driven care
-
From Digital Twin Transition to Climate Neutrality - Estonian Roadmap Unveiled at COP28
-
citizenM Menlo Park Hotel Jointly Built by CIMC Group Officially Opened in Silicon Valley, USA
-
CM Energy Led Consortium Won US$163.8 Million Order for Oil Rig Moderation and O&M Services in Mexico
-
Live from ASH 2023 | Ascentage Pharma Presents Updated Data from US Study of Olverembatinib, Further Validating Encouraging Efficacy in Patients Resistant to Ponatinib or Asciminib
-
Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73.3%
-
Crestbridge Bahrain Announces Strategic Rebrand To Yasira
-
CELEBRITIES, DIGNITARIES AND NONPROFIT LEADERS FROM ACROSS THE GLOBE HONOR HOLOCAUST SURVIVORS ON INTERNATIONAL HOLOCAUST SURVIVORS NIGHT ON DECEMBER 11, 2023
-
Live from ASH 2023 | Ascentage Pharma Releases the First Dataset of Bcl-2 Inhibitor Lisaftoclax in Patients with R/R MM, Demonstrating Encouraging ORR and VGPR
-
DHGATE Group Co-CEO Chun Li, Addresses the 2023 GoGlobal Forum of 100, Advocates for Enhanced Services to Uplift Global Small Businesses
-
Year-Round Magic: Wego Teams Up with Moroccan National Tourist Office for Unforgettable Journeys
-
InfiRay Plans to Unveil Its Latest Car Night Vision AI System at CES 2024
-
Keppel partners AM Green to explore biogenic carbon-based sustainable fuels opportunities in Asia and the Middle East
-
ACX Partners with B3 Connecting Brazil to the Global Carbon Markets
-
ChuanQi IP Launches Teaser Site for <MIR2M : The Grandmaster>
-
MGI Expands Presence in Latin America with New Partnerships with Genos Médica and TCL Group
-
Last Fortress x The Boys Collaboration Round 2! Homelander, Soldier Boy, and A-Train Join the Fight!
-
AndaSeat Unveils a Festive Collection of Gaming Gear: Gaming in a Winter Wonderland
-
Zetrix and Beitou Launch Digital ID & Driver's Licence Services on Blockchain
-
TECNO Launches Three Pioneering Technologies at its Annual Future Lens 2023 Event
-
Karyopharm Shares Data at ASH 2023 Showing Strong SVR and TSS Durability Observed from Phase 1 Study of Selinexor 60mg and Ruxolitinib in JAK Inhibitor (JAKi)-Naïve Myelofibrosis Patients, with no SV
-
Sustainability Empowerment, Brand Upgrade VIVOTEK among Taiwan's Best Global Brands
-
Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery
-
Xinhua Silk Road: China's Bama Tea shares tea culture and seeks cooperation at Belt and Road forum
-
Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
-
Antengene Announces the Study of Anti-CD24 Monoclonal Antibody ATG-031 Dosed Its First Patient in the United States
-
Maine Condo Project to Offer Turnkey Restoration Hardware Units
-
Astellas' VEOZA™ (fezolinetant) Approved by European Commission for Treatment of Vasomotor Symptoms Associated with Menopause
-
Belgian Commitment to Partnership Supports a New Frontier of Europe-US Space Research
-
Taiho Oncology Announces Presentation of Data From a U.S. Real-Word Study of Oral Decitabine and Cedazuridine
-
Belgium and Lockheed Martin Celebrate Rollout of First F-35A for Belgium
-
Remedy Plan Therapeutics to Showcase Novel NAMPT Inhibitor During Oral Presentation at 2023 American Society of Hematology (ASH) Annual Meeting
-
Empowering the Season of Giving: Annual Holiday Canteen Drive Brings Aid to Incarcerated Women
-
The Cigna Group Announces Significant Increase to Share Repurchase Program of $10 Billion
-
SAMARITAN'S PURSE DEPLOYS ASSESSMENT TEAM TO TENNESSEE AFTER DEADLY TORNADOES
-
Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting
-
Poseida Therapeutics Presents Positive Early Results from its Phase 1 Trial of Allogeneic CAR-T P-BCMA-ALLO1 in Relapsed-Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) An
-
Aqua Bridge Group and Enertech launch Aqua Bridge Kuwait at COP28, in boost for local food systems and fisheries
-
Studies Highlight Both Novel Treatments and Enduring Value of Older Approaches
-
Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane®
-
Freedom, Equality and Justice Lead to Peace


